International First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension

NCT01836146 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Renal Denervation

Interventions

DEVICE: EnligHTN™ Renal Artery Ablation Catheter

Sponsor

Abbott Medical Devices